Medicare Enrolled
Dr. Vitaly Margulis, MD
Urology Physician · Dallas, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Margulis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Margulis?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Margulis
Dr. Vitaly Margulis is an urology physician in Dallas, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Margulis performed 3,533 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Margulis received a total of $495,808 from 39 pharmaceutical and/or device companies across 548 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Margulis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 34% volume in TX
$495,808 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,533
Medicare services
Top 34% in TX for urology physician
Not available
Unique patients (not deduplicated)
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, docetaxel, 1 mg | 1,880 | $0 | $4 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
471 | $89 | $344 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 240 | $3 | $395 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
150 | $177 | $837 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
131 | $3 | $18 |
| New patient office visit, complex (60-74 min) | 120 | $138 | $664 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 99 | $129 | $2,030 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
67 | $55 | $468 |
| Surgical removal of prostate and lymph nodes This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope. |
40 | $719 | $7,081 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
38 | $199 | $1,356 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
38 | $120 | $464 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
32 | $8 | $80 |
| Bladder procedure using endoscope A procedure performed on the bladder using an endoscope, which is a thin, flexible tube with a camera used to view the inside of the organ. |
28 | $1,529 | $8,389 |
| Endoscopic removal of pelvic lymph nodes, bilateral A surgical procedure to remove lymph nodes from both sides of the pelvis using an endoscope. This minimally invasive technique involves making small incisions to access and excise the tissue. |
27 | $258 | $3,223 |
| Partial kidney removal using endoscope Surgical removal of part of the kidney through a small incision using an endoscope. This minimally invasive technique allows for targeted tissue removal without large open incisions. |
23 | $1,144 | $5,836 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
23 | $96 | $2,172 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
22 | $10 | $340 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
22 | $26 | $143 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
20 | $16 | $75 |
| Bladder tumor removal via endoscope This procedure involves using an endoscope to destroy or remove a large growth from the bladder. |
17 | $293 | $2,128 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $66 | $232 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
16 | $18 | $60 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
12 | $52 | $138 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.7% high complexity
62.0% medium
37.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$495,808
Total received (2018-2024)
Avg $70,830/year across 7 years
Top 1% in TX for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
548
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$80,813
2023
$68,202
2022
$132,149
2021
$13,371
2020
$4,218
2019
$61,216
2018
$135,838
Payments by company (2024)
Janssen Biotech, Inc.
$34,151
PROGENICS PHARMACEUTICALS, INC.
$31,442
Merck Sharp & Dohme LLC
$14,019
Medtronic, Inc.
$238
IMMUNITYBIO, INC.
$150
Ethicon US, LLC
$138
UROGEN PHARMA, INC.
$125
Myriad Genetic Laboratories, Inc.
$121
Janssen Scientific Affairs, LLC
$117
Astellas Pharma US Inc
$115
Blue Earth Diagnostics Limited
$100
Innovation Technologies Inc
$49
Laborie Medical Technologies Corp.
$48
Top 3 companies account for 98.5% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$149,379
Janssen Scientific Affairs, LLC
$126,575
Merck Sharp & Dohme LLC
$71,905
Progenics Pharmaceuticals, Inc.
$51,865
PROGENICS PHARMACEUTICALS, INC.
$31,442
UroGen Pharma, Inc.
$20,709
Intuitive Surgical, Inc.
$10,643
Merck Sharp & Dohme Corporation
$9,640
Blue Earth Diagnostics Limited
$6,632
Eisai Inc.
$4,100
Bayer HealthCare Pharmaceuticals Inc.
$2,897
E.R. Squibb & Sons, L.L.C.
$2,497
Ethicon US, LLC
$959
Photocure Inc
$632
Endo Pharmaceuticals Inc.
$500
Dendreon Pharmaceuticals LLC
$494
Myriad Genetic Laboratories, Inc.
$489
Medtronic, Inc.
$458
PROCEPT BioRobotics Corporation
$447
CONMED Corporation
$439
AstraZeneca Pharmaceuticals LP
$350
Boston Scientific Corporation
$280
UROGEN PHARMA, INC.
$257
Astellas Pharma US Inc
$244
BOSTON SCIENTIFIC CORPORATION
$232
KARL STORZ Endoscopy-America
$226
Telix Pharmaceuticals
$182
Myovant Sciences Inc.
$180
AVEO Pharmaceuticals, Inc.
$168
Sumitomo Pharma America, Inc.
$167
IMMUNITYBIO, INC.
$150
Foundation Medicine, Inc.
$139
Laborie Medical Technologies Corp.
$122
TOLMAR Pharmaceuticals, Inc.
$109
Bayer Healthcare Pharmaceuticals Inc.
$106
Profound Medical Corp.
$72
Covidien LP
$56
Innovation Technologies Inc
$49
PFIZER INC.
$15
Top 3 companies account for 70.2% of all-time payments
Associated products mentioned in payments ›
0.30MM · 16 FR. FLEXIBLE VIDEO CYSTOSCOPE · 24/26 FR. · AIRSEAL · AMS 800 Artificial Urinary Sphincter · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · Axumin · BIPOLAR · CUTTING LOOP · CYSVIEW · Cysview · Da Vinci Surgical System · ELIGARD · ERLEADA · Echelon Flex · Enseal X1 · Erleada · FLEXIBLE VIDEO URETHRO-CYSTOSCOPE · FOTIVDA · FOUNDATIONONE · GENERAL THERAPIES · GREENLIGHT · ILLUCCIX · INTERSTIM · IRRISEPT · JELMYTO · KEYTRUDA · LYNPARZA · Lenvima · LithoVue · Monosof · Nubeqa · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · SURGIFLO Hemostatic Matrix Family of Products · Tulsa-Pro · VISTASEAL · XTANDI · Xofigo · Xtandi
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
155
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
UT OF TEXAS SOUTHWESTERN UNIVERSITY HOSPITAL - WILLIAM P. CLEMENTS JR.
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Margulis is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Margulis experienced with injection, docetaxel, 1 mg?
Based on Medicare claims data, Dr. Margulis performed 1,880 injection, docetaxel, 1 mg services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Margulis receive payments from pharmaceutical companies?
Yes. Dr. Margulis received a total of $495,808 from 39 companies across 548 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Margulis's costs compare to other urology physicians in Dallas?
Dr. Margulis's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Margulis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Dallas
Browse urology physicians in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Janssen Scientific Affairs, LLC Payments to Doctors
See all physicians who received payments from Janssen Scientific Affairs, LLC.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology